NR1H4 and hepatocellular carcinoma: In HCC and colorectal cancer, it was reported that FXR binds with β-catenin to block the formation of the core β-catenin/TCF4 complex, which promotes cyclinD1 expression for tumour cell proliferation [13, 14].